YOUR BUSINESS AUTHORITY
Springfield, MO
In an $8.3 billion deal, San Francisco-based health care services firm McKesson Corp. (NYSE: MCK) will acquire a 50.01 percent controlling stake in German drug wholesaler Celesio.
The New York Times reports the deal would create one of the world’s largest pharmaceutical wholesalers and providers of logistics and services in the health care sector, with annual revenue of more than $150 billion and about 81,500 employees worldwide. The combined company would operate in 20 countries.
MCK shares soared on news of the deal, reaching $155 for its highest intraday value since shares began trading in August 1994. The stock had gained 60 percent during the past 12 months.
If given the regulatory go-ahead by German financial authorities and regulators in Austria, Ireland and Slovenia, McKesson expects to assume operations during its fiscal 2015, which begins in April.
Read more from the New York Times.
[[In-content Ad]]A City Utilities employee since 2017 with a 25-year legal background, he now leads the municipal utility provider with an $895 million annual budget.
City employee dies in landfill accident
Kehoe appoints 3 locals to state boards, commission
Spring 2025 Architects & Engineers Project Report
Letter to the Editor: These candidates embody unity, collaboration, independence
Council postpones vote on tax payment requirement for occupational licenses